The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lynch, E. A.
Right arrow Articles by Cruikshank, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lynch, E. A.
Right arrow Articles by Cruikshank, W. W.
The Journal of Immunology, 2003, 171: 4965-4968.
Copyright © 2003 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: IL-16/CD4 Preferentially Induces Th1 Cell Migration: Requirement of CCR5 1

Elizabeth A. Lynch, Claudia A. W. Heijens, Noah F. Horst, David M. Center and William W. Cruikshank2

Boston University Medical Center, Boston University School of Medicine, Boston, MA 02118

IL-16 binds to CD4 and induces a migratory response in CD4+ T cells. Although it has been assumed that CD4 is the sole receptor and that IL-16 induces a comparable migratory response in all CD4+ T cells, this has not been investigated. In this study, we determined that IL-16 preferentially induces a migratory response in Th1 cells. Because chemokine receptor CCR5 is expressed predominantly in Th1 cells and is physically associated with CD4, we investigated whether IL-16/CD4 stimulation was enhanced in the presence of CCR5. Using T cells from CCR5null mice, we determined that IL-16-induced migration was significantly greater in the presence of CCR5. The presence of CCR5 significantly increased IL-16 binding vs CD4 alone; however, IL-16 could not bind to CCR5 alone. Because CD4+CCR5+ cells are prevalent at sites of inflammation, this intimate functional relationship likely plays a pivotal role for the recruitment and activation of Th1 cells.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
P. Camateros, C. Kanagaratham, J. Henri, R. Sladek, T. J. Hudson, and D. Radzioch
Modulation of the allergic asthma transcriptome following resiquimod treatment
Physiol Genomics, August 7, 2009; 38(3): 303 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Gu, D. F. Lewis, K. Deere, L. J. Groome, and Y. Wang
Elevated Maternal IL-16 Levels, Enhanced IL-16 Expressions in Endothelium and Leukocytes, and Increased IL-16 Production by Placental Trophoblasts in Women with Preeclampsia
J. Immunol., September 15, 2008; 181(6): 4418 - 4422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. O. Tzianabos, M. A. Holsti, X.-X. Zheng, A. F. Stucchi, V. K. Kuchroo, T. B. Strom, L. H. Glimcher, and W. W. Cruikshank
Functional Th1 Cells Are Required for Surgical Adhesion Formation in a Murine Model
J. Immunol., May 15, 2008; 180(10): 6970 - 6976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. McFadden, R. Morgan, S. Rahangdale, D. Green, H. Yamasaki, D. Center, and W. Cruikshank
Preferential Migration of T Regulatory Cells Induced by IL-16
J. Immunol., November 15, 2007; 179(10): 6439 - 6445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Numasaki, M. Tagawa, F. Iwata, T. Suzuki, A. Nakamura, M. Okada, Y. Iwakura, S. Aiba, and M. Yamaya
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
J. Immunol., April 15, 2007; 178(8): 5086 - 5098.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. J. Crane, H. Xu, C. Wallace, A. Manivannan, M. Mack, J. Liversidge, G. Marquez, P. F. Sharp, and J. V. Forrester
Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
J. Leukoc. Biol., March 1, 2006; 79(3): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank
Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol
J. Immunol., February 15, 2006; 176(4): 2337 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ren, X. Zhan, G. Martens, J. Lee, D. Center, S. K. Hanson, and H. Kornfeld
Pro-IL-16 Regulation in Activated Murine CD4+ Lymphocytes
J. Immunol., March 1, 2005; 174(5): 2738 - 2745.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. P. Widney, Y. Hu, A. K. Foreman-Wykert, K. C. Bui, T. T. Nguyen, B. Lu, C. Gerard, J. F. Miller, and J. B. Smith
CXCR3 and Its Ligands Participate in the Host Response to Bordetella bronchiseptica Infection of the Mouse Respiratory Tract but Are Not Required for Clearance of Bacteria from the Lung
Infect. Immun., January 1, 2005; 73(1): 485 - 493.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. D. Bella, S. Nicola, I. Timofeeva, M. L. Villa, A. Santoro, and A. C. Berardi
Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?
Blood, December 15, 2004; 104(13): 4020 - 4028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ferland, N. Flamand, F. Davoine, J. Chakir, and M. Laviolette
IL-16 Activates Plasminogen-Plasmin System and Promotes Human Eosinophil Migration into Extracellular Matrix via CCR3-Chemokine-Mediated Signaling and by Modulating CD4 Eosinophil Expression
J. Immunol., October 1, 2004; 173(7): 4417 - 4424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Pritchard, S. Tsui, N. Horst, W. W. Cruikshank, and T. J. Smith
Synovial Fibroblasts from Patients with Rheumatoid Arthritis, Like Fibroblasts from Graves' Disease, Express High Levels of IL-16 When Treated with Igs against Insulin-Like Growth Factor-1 Receptor
J. Immunol., September 1, 2004; 173(5): 3564 - 3569.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.